Another study showed that the progression of prostate cancer in the xenograft model was inhibited by triptolide via limited SUMO-specific protease 1 activity (SENP1), as well as androgen receptor expression and c-Jun transcription activity. This evidence concerns the gene AR and prostate carcinoma.